Skip to main content
Equibles

UBS Group AG

Position in INMB — Inmune Bio, Inc.

CIK 1610520 ZURICH, V8
Back to INMB Full portfolio

Position in INMB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$179,972
-$106,302 QoQ
Shares Held
110,413
-56.4% QoQ
Ownership
0.398%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#10
of 83 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 21% Shared 0% None 79%

Common Shares in INMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. INMB ranks #341 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in INMB

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $179,972 110,413
2026-03-31 $286,274 253,340
2025-12-31 $94,852 60,803
2025-09-30 $321,930 155,522
2025-06-30 $1,037,698 449,221
2025-03-31 $1,072,429 137,315
2024-12-31 $636,278 136,248
2024-09-30 $232,610 43,156
2024-06-30 $355,384 40,293
2024-03-31 $450,025 38,300
2023-12-31 $486,600 43,215
2023-09-30 $283,324 41,850
2023-06-30 $474,430 52,250
2023-03-31 $346,540 53,644
2022-12-31 $285,490 45,030
2022-09-30 $247,690 39,950
2022-06-30 $344,318 38,950
2022-03-31 $302,699 35,950
2021-12-31 $366,690 35,950
2021-09-30 $585,046 30,126
2021-06-30 $130,826 7,446
2021-03-31 $39,310 3,309
2020-12-31 $4,305 250
2020-06-30 $4,305 820
2020-03-31 $3,759 1,129